YOUNGENE

Youngene is developing a next-gen SGLT inhibitor to improve the lives of the millions living with diabetes, heart failure, and renal impairment... Youngene Therapeutics Co. Ltd. is headquartered in the ZhangJiang Medicine Valley located in Shanghai, China. We are an innovative biopharmaceutical enterprise focused on the development of novel therapeutics for the treatment of metabolic and cardiovascular diseases including diabetes and heart failure. We have won numerous local industry awards for our outstanding research and development capabilities.

Also known as: Youngene Therapeutics Co. Ltd.

Primary location: Shanghai China